Prof Gemma Figtree AM MBBS (Hons) DPhil (Oxon), FRACP, FCSANZ, FAHA, GAICD
University of Sydney
SMuRFless Coronary Artery Disease (CAD) Symposium Register Now
Join Us for the Inaugural SMuRFless CAD Symposium 23-24 August 2023 Amsterdam, Netherlands
The development of coronary artery disease (CAD) and myocardial infarction (MI) in the absence of SMuRFs (“SMuRFless”) has been highlighted as an area of unmet clinical need. It is believed to account for between 10-27 percent of ST elevation MI and associated with higher 30-day mortality.
This has sparked global interest, demonstrated by a rapid rise in publications in leading international journals.
The inaugural SMuRFless CAD Symposium will include global clinical and scientific leaders with presentations and facilitated discussions on:
Clinical characteristics and outcomes;
Unmet needs in early detection and treatments; and
Drug translation and evidence building
Register your attendance using the link below by 14 August 2023.
Scientific Program Committee
Prof Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Mount Sinai Heart
Prof Keith Channon MB ChB Med (Hons) MRCP MD FRCP
University of Oxford
Dr Nicholas Chew MBChB MMED MRCP (UK)
National University Heart Centre Singapore
Prof Peter Libby MD
Harvard Medical School
Prof Roxana Mehran MD, FACC, FACP, FCCP, FESC, FAHA, FSCA
Mount Sinai
Prof Phillipe Gabriel Steg MD
Université de Paris
Dr Stephen Vernon BMedSci, MBBS, PhD, FRACP
University of Sydney
Our Sponsors
Thank you to our generous sponsors.